Tectonic Therapeutic (TECX) Preferred Dividend Payments (2017 - 2018)
Tectonic Therapeutic (TECX) posted quarterly Preferred Dividend Payments of $2.2 million for Q1 2018, up 5802.63% quarter-over-quarter from $38000.0 in Q4 2017.
Analysis
Tectonic Therapeutic (TECX) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Preferred Dividend Payments for 2 consecutive years, with $2.2 million the latest figure, recorded in Q1 2018.
- In Q1 2018, Preferred Dividend Payments changed N/A year-over-year to $2.2 million; the TTM figure through Dec 2018 stood at $2.2 million (changed N/A YoY), while the FY2018 annual figure was $2.2 million, up 2538.82% from the prior year.
- Preferred Dividend Payments advanced to $2.2 million in Q1 2018 per TECX's latest filing, from $38000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.2 million in Q1 2018 and bottomed at $38000.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 10 | Tectonic Therapeutic | 569.49 Mn | 569.49 Mn | - | - |